MX2024009755A - Metodos de purificacion de un producto. - Google Patents

Metodos de purificacion de un producto.

Info

Publication number
MX2024009755A
MX2024009755A MX2024009755A MX2024009755A MX2024009755A MX 2024009755 A MX2024009755 A MX 2024009755A MX 2024009755 A MX2024009755 A MX 2024009755A MX 2024009755 A MX2024009755 A MX 2024009755A MX 2024009755 A MX2024009755 A MX 2024009755A
Authority
MX
Mexico
Prior art keywords
product
methods
purifying
affinity chromatography
purification
Prior art date
Application number
MX2024009755A
Other languages
English (en)
Spanish (es)
Inventor
Andreas Sebastian Zurbriggen
Carole In-Albon
Original Assignee
Kodiak Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kodiak Sciences Inc filed Critical Kodiak Sciences Inc
Publication of MX2024009755A publication Critical patent/MX2024009755A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/248—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MX2024009755A 2022-02-10 2023-02-09 Metodos de purificacion de un producto. MX2024009755A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263267810P 2022-02-10 2022-02-10
PCT/US2023/062322 WO2023154822A2 (en) 2022-02-10 2023-02-09 Methods of purifying a product

Publications (1)

Publication Number Publication Date
MX2024009755A true MX2024009755A (es) 2024-08-20

Family

ID=87521638

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024009755A MX2024009755A (es) 2022-02-10 2023-02-09 Metodos de purificacion de un producto.

Country Status (10)

Country Link
US (1) US20230250133A1 (cg-RX-API-DMAC7.html)
EP (1) EP4476237A2 (cg-RX-API-DMAC7.html)
JP (1) JP2025505696A (cg-RX-API-DMAC7.html)
KR (1) KR20240142564A (cg-RX-API-DMAC7.html)
CN (1) CN119032099A (cg-RX-API-DMAC7.html)
AU (1) AU2023217074A1 (cg-RX-API-DMAC7.html)
CA (1) CA3251000A1 (cg-RX-API-DMAC7.html)
IL (1) IL314472A (cg-RX-API-DMAC7.html)
MX (1) MX2024009755A (cg-RX-API-DMAC7.html)
WO (1) WO2023154822A2 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2819217T3 (es) 2013-09-08 2021-04-15 Kodiak Sciences Inc Conjugados de polímeros iónicos dipolares y factor VIII
CA3059938A1 (en) 2017-04-14 2018-10-18 Kodiak Sciences Inc. Complement factor d antagonist antibodies and conjugates thereof
CA3092588A1 (en) 2018-03-02 2019-09-06 Kodiak Sciences Inc. Il-6 antibodies and fusion constructs and conjugates thereof
CA3157509A1 (en) 2019-10-10 2021-04-15 Kodiak Sciences Inc. Methods of treating an eye disorder
AU2021377336A1 (en) * 2020-11-16 2023-07-06 Prothera Biologics, Inc. Methods for purifying inter-alpha inhibitor proteins
EP4788450A1 (en) * 2023-10-04 2026-08-12 Sartorius BIA Separations d.o.o. Enhanced chromatographic separations of components in a mixture by employing chaotropic elution
WO2025184423A1 (en) * 2024-02-29 2025-09-04 Kodiak Sciences Inc. Cell-surface-targeting-domain-polymer-payload conjugate
US20260070966A1 (en) * 2024-09-06 2026-03-12 Eyebiotech Limited Multivalent fzd4, wnt co-receptor, and vegf receptor molecules and uses thereof
US20260092125A1 (en) * 2024-09-06 2026-04-02 Eyebiotech Limited Multivalent fzd4, wnt co-receptor, and vegf binding molecules and uses thereof
WO2026075981A1 (en) * 2024-10-01 2026-04-09 Regeneron Pharmaceuticals, Inc. Methods of analyzing heterodimeric proteins
CN119454939A (zh) * 2024-11-28 2025-02-18 北海康成(苏州)生物制药有限公司 一种欧莫扑拜单抗原液及其制备方法
CN119524125A (zh) * 2024-11-28 2025-02-28 北海康成(苏州)生物制药有限公司 一种欧莫扑拜单抗原液的生产方法及欧莫扑拜单抗原液

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045314B2 (en) * 2000-04-04 2006-05-16 Baxter International Inc. Method for the production of bacterial toxins
CN102395597A (zh) * 2009-03-11 2012-03-28 惠氏有限责任公司 纯化小模块免疫药物蛋白的方法
CA2853358A1 (en) * 2011-10-24 2013-05-02 Halozyme, Inc. Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
WO2015101586A1 (en) * 2014-01-03 2015-07-09 F. Hoffmann-La Roche Ag Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles
CN110981957B (zh) * 2014-01-15 2024-12-24 豪夫迈·罗氏有限公司 具有改善的蛋白A结合作用的Fc区变体
EP3054007A1 (en) * 2015-02-09 2016-08-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
JP6959912B2 (ja) * 2015-09-23 2021-11-05 ジェネンテック, インコーポレイテッド 抗vegf抗体の最適化変異体
IL290457B2 (en) * 2015-12-30 2025-02-01 Kodiak Sciences Inc Antibodies and their conjugates
CA3092588A1 (en) * 2018-03-02 2019-09-06 Kodiak Sciences Inc. Il-6 antibodies and fusion constructs and conjugates thereof
US20210254073A1 (en) * 2020-02-04 2021-08-19 Cornell University Methods for capture and analysis of macromolecular complexes

Also Published As

Publication number Publication date
JP2025505696A (ja) 2025-02-28
AU2023217074A1 (en) 2024-08-15
IL314472A (en) 2024-09-01
EP4476237A2 (en) 2024-12-18
CN119032099A (zh) 2024-11-26
WO2023154822A3 (en) 2023-09-21
WO2023154822A8 (en) 2024-04-04
WO2023154822A2 (en) 2023-08-17
KR20240142564A (ko) 2024-09-30
CA3251000A1 (en) 2023-08-17
US20230250133A1 (en) 2023-08-10

Similar Documents

Publication Publication Date Title
WO2023154822A8 (en) Methods of purifying a product
De Luca et al. Downstream processing of therapeutic peptides by means of preparative liquid chromatography
MX2015005178A (es) Purificacion de polipeptidos usando ultrafiltracion de flujo tangencial de etapa doble.
PL374311A1 (en) Methods for purifying protein
WO2002083710A3 (en) Removal of bacterial endotoxin in a protein solution by immobilized metal affinity chromatography
EP2729570B1 (en) Reagent usable for the isolation and/or purification of nucleic acids
MX2012001263A (es) Metodo para purificar adamts13 recombinante y otras proteinas y sus composiciones.
US12358946B2 (en) Method for purifying antibodies
RU2011137030A (ru) Способы очистки малых модулярных иммунофармацевтических белков
CN109096379B (zh) 一种枯草芽孢杆菌amep412蛋白的新功能及其抗菌肽的鉴定
Careri et al. Analysis of food proteins and peptides by chromatography and mass spectrometry
Luong et al. A continuous affinity ultrafiltration process for trypsin purification
Dyr et al. Separation used for purification of recombinant proteins
Rito-Palomares et al. Generic application of an aqueous two-phase process for protein recovery from animal blood
WO2020127505A1 (en) A method for removing nucleosomal contaminants from bioprocessing solutions
GEAP202516778A (en) Arginine wash in protein purification
Gräslund et al. Integrated strategy for selective expanded bed ion-exchange adsorption and site-specific protein processing using gene fusion technology
Balekjian et al. Histones isolated from human parotid fluid
Mönster et al. One-step-purification of penicillin G amidase from cell lysate using ion-exchange membrane adsorbers
Garmidolova et al. Food-derived bioactive peptides-methods for purification and analysis
Roe Protein purification applications: a practical approach
CN105112394A (zh) 一种能降解黄曲霉毒素b1的裂解酶的分离纯化方法
Recio et al. Method for the production of antibacterial peptides from biological fluids at an ionic membrane. Application to the isolation of nisin and caprine lactoferricin
Karabel’skii et al. Purification of the chimeric protein alburon16 from a culture medium of the yeast Pichia pastoris
Miller et al. Biochemical characterization of the antimicrobial histone released by deoxyribonuclease and lactic acid